Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001193125-25-320941

Chief Discovery Officer sold 8,000 shares at $22.64 ($181,159)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bensen Daniel Chief Discovery Officer 2025-12-12 Sale 10b5-1 −8,000 $22.64 $181,159 162,981 D: show line 1 in the form
Open-market sales · 8,000 sh · avg $22.64 · $181,159
Loading xslF345X05/ownership.xml…